Trends in Antibiotic Susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014

Sanjat Kanjilal1,2, Mohamad R Abdul Sater3, Maile Thayer3

  • 1Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA skanjilal@bwh.harvard.edu ygrad@hsph.harvard.edu.

Insights

Infections from Staphylococcus aureus, including MRSA, have decreased. This trend is linked to increased antibiotic susceptibility, making penicillin a more effective treatment option for S. aureus infections.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Genomics

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) infections have declined, prompting an investigation into overall Staphylococcus aureus (S. aureus) infection trends.
  • Understanding shifts in S. aureus subtypes and antibiotic resistance is crucial for public health strategies.

Purpose of the Study:

  • To evaluate trends in annual S. aureus infection rates, including subtypes and antibiotic resistance, over a 15-year period.
  • To analyze the genetic basis for resistance changes in S. aureus isolates.

Main Methods:

  • A 15-year retrospective observational study of 31,753 adult inpatients at two tertiary care institutions in Boston, MA.
  • Genome sequencing of 180 S. aureus isolates from 2016 to infer resistance gene dynamics.
  • Analysis of annual infection rates for S. aureus, MRSA, penicillin-susceptible S. aureus (PSSA), and methicillin-susceptible penicillin-resistant S. aureus (MSSA).

Main Results:

  • Overall S. aureus infection rates declined by 4.2% annually from 2003 to 2014, primarily due to a 10.9% annual decline in MRSA.
  • Penicillin-susceptible S. aureus (PSSA) rates increased by 6.1% annually, while methicillin-susceptible penicillin-resistant S. aureus (MSSA) rates remained stable.
  • A decrease in the average number of antibiotics to which S. aureus was resistant was observed, with some MSSA and PSSA isolates showing loss of resistance genes.

Conclusions:

  • S. aureus infections have declined in Boston tertiary care institutions, marked by a significant decrease in MRSA and an increase in PSSA.
  • The observed shift towards increased antibiotic susceptibility in S. aureus suggests penicillin is becoming a more viable treatment option.
  • Genetic analysis revealed instances of resistance gene loss contributing to the observed increase in antibiotic susceptibility.